Oncolytics Biotech Inc. (ONCY) News
Track canonical SquawkNews coverage tagged to ONCY, Oncolytics Biotech Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Onconvex (ONCY) price target cut from $10 to $5, keeps Buy
Hammerstone MarketTalk cuts Onconvex (ONCY) price target from $10 to $5 while maintaining a Buy rating at HCW, per the note.
EQUITY | Aug 19, 2026, 12:21 PM UTC
M
Oncolytics Biotech aligns with FDA on registrational path
Oncolytics Biotech (ONCY) says it has aligned with the FDA on the registrational path for second-line RAS-mutant MSS colorectal cancer.
REGULATION | Aug 18, 2026, 01:03 PM UTC
L
Oncolytics announces FDA Fast Track designation for pelareorep
Oncolytics announced that...
REGULATION | Jul 20, 2026, 01:03 PM UTC